遠東發展(00035.HK):Tang City行使所有選擇權購買相關物業
格隆匯9月28日丨遠東發展(00035.HK)公佈,於2020年8月26日,賣方FEC Skyline Pte. Ltd.(作為授予人,公司間接非全資附屬公司),就共同買賣該等物業向買方Tang City Homes Pte Ltd(作為承授人)發出選擇權協議,該等物業位於該發展項目(建於或將建於政府重新測量地段編號03995V及領空地段編號70002V(同為Mukim 1, Singapore)名為或將名稱ARTRA的樓宇)的10個商業單位。
於2020年9月28日,買方已同時行使所有選擇權並與賣方訂立買賣協議,據此,賣方將出售而買方將按代價購買該等物業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.